Richard W Mott - Net Worth and Insider Trading

Richard W Mott Net Worth

The estimated net worth of Richard W Mott is at least $7 Million dollars as of 2024-12-29. Richard W Mott is the Director of Treace Medical Concepts Inc and owns about 1,072,944 shares of Treace Medical Concepts Inc (TMCI) stock worth over $7 Million. Details can be seen in Richard W Mott's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard W Mott has not made any transactions after 2024-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard W Mott

To

Richard W Mott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard W Mott owns 3 companies in total, including Endologix Inc (ELGXQ) , Lyra Therapeutics Inc (LYRA) , and Treace Medical Concepts Inc (TMCI) .

Click here to see the complete history of Richard W Mott’s form 4 insider trades.

Insider Ownership Summary of Richard W Mott

Ticker Comapny Transaction Date Type of Owner
ELGXQ Endologix Inc 2020-06-19 director
LYRA Lyra Therapeutics Inc 2020-04-30 10 percent owner
TMCI Treace Medical Concepts Inc 2024-05-24 director

Richard W Mott Latest Holdings Summary

Richard W Mott currently owns a total of 1 stock. Richard W Mott owns 1,072,944 shares of Treace Medical Concepts Inc (TMCI) as of May 24, 2024, with a value of $7 Million.

Latest Holdings of Richard W Mott

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TMCI Treace Medical Concepts Inc 2024-05-24 1,072,944 6.98 7,489,149

Holding Weightings of Richard W Mott


Richard W Mott Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard W Mott has made a total of 16 transactions in Treace Medical Concepts Inc (TMCI) over the past 5 years, including 3 buys and 13 sells. The most-recent trade in Treace Medical Concepts Inc is the acquisition of 18,000 shares on May 24, 2024, which cost Richard W Mott around $93,420.

Insider Trading History of Richard W Mott

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard W Mott Trading Performance

GuruFocus tracks the stock performance after each of Richard W Mott's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard W Mott is 24.91%. GuruFocus also compares Richard W Mott's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard W Mott within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard W Mott's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard W Mott

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.7 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.45 LIMIT LIMIT LIMIT LIMIT LIMIT

Richard W Mott Ownership Network

Ownership Network List of Richard W Mott

No Data

Ownership Network Relation of Richard W Mott

Insider Network Chart

Richard W Mott Owned Company Details

What does Endologix Inc do?

Who are the key executives at Endologix Inc?

Richard W Mott is the director of Endologix Inc. Other key executives at Endologix Inc include director & CEO and Director John Onopchenko , Chief Medical Officer Matthew Thompson , and Controller and Corp Secretary Timothy Nicholas Brady .

Endologix Inc (ELGXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Endologix Inc (ELGXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endologix Inc (ELGXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endologix Inc (ELGXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Endologix Inc Insider Transactions

No Available Data

Richard W Mott Mailing Address

Above is the net worth, insider trading, and ownership report for Richard W Mott. You might contact Richard W Mott via mailing address: 1221 Crossman Avenue, Sunnyvale Ca 94089.

Discussions on Richard W Mott

No discussions yet.